BioPharmGuy logo
Sponsored By:
Trianni Inc.
BioPharmGuy Database
Emery Pharma
Kolltan Pharmaceuticals is defunct.

Fate: Bought by Celldex, Nov 2016, $62.5M + $172.5M milestones


------------------
If you believe any of this information is incorrect, please let us know.